Background illustration for clinical trials search

Paid Clinical Trials Torrance

Discover 3,494 paid clinical trials in Torrance, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

for
Advanced Systemic Mastocytosis (AdvSM),
Location: Los Angeles CA, Duarte CA, Stanford CA, Phoenix AZ,
Sponsor: Cogent Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT04996875

Phase 2, Recruiting

A Study of Buntanetap in Participants With PD

for
Parkinson's Disease (PD), Deep Brain Stimulation
Location: Fountain Valley CA, Sun City AZ, Englewood CO,
Sponsor: Annovis Bio Inc.

Sex: All

Age: 40 - 70+

Code: NCT07284784

Phase 2, Phase 3, Recruiting

StrokeNet Thrombectomy Endovascular Platform

for
Ischemic Stroke
Location: Los Angeles CA, La Jolla CA, San Diego CA, Stanford CA,
Sponsor: Medical University of South Carolina

Sex: All

Age: 18+

Code: NCT06289985

Recruiting

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

for
Metabolic Dysfunction-associated Steatohepatitis
Location: Long Beach CA, Fountain Valley CA, Orange CA,
Sponsor: Eccogene

Sex: All

Age: 18 - 70+

Code: NCT07288138

Phase 2, Recruiting

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation,
Location: Los Angeles CA, Orange CA, La Jolla CA, Phoenix AZ,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05735184

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Fractional Handpiece With CO2 Laser: Fractional Ablative Laser Treatment of Vulvovaginal Atrophy

for
Vulvovaginal Atrophy
Location: Agoura Hills CA
Sponsor: SHERRY Thomas

Sex: Female

Age: 40 - 70+

Code: NCT03271944

Recruiting

Evaluation Using Intragen Fractional Radiofrequency With NeuViVa for the Treatment of Vaginal Laxity and Urogynecology Symptoms.

for
Vaginal Laxity, Urinary Incontinence, Sexual Dysfunction
Location: Agoura Hills CA
Sponsor: SHERRY Thomas

Sex: Female

Age: 18+

Code: NCT03280446

Recruiting

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

for
Advanced Breast Cancer, Metastatic Breast Cancer (HR+/ HER2-),
Location: Duarte CA, West Valley City UT, San Antonio TX,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07318805

Phase 1, Recruiting

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

for
Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma, RCC,
Location: Duarte CA, San Diego CA, Dallas TX, Omaha NE,
Sponsor: Neomorph, Inc

Sex: All

Age: 18+

Code: NCT07300241

Phase 1, Recruiting

Prescription of Letrozole for Uterine Myoma

for
Leiomyoma, Uterine, Leiomyoma, Fibroid, Fibroid Uterus
Location: Los Angeles CA, San Francisco CA, Rochester MN,
Sponsor: University of California, San Francisco

Sex: Female

Age: 21 - 53

Code: NCT06143631

Recruiting

Multilevel Determinants of Socioeconomic Disparities in Geographic Late-Stage Hepatocellular Carcinoma Hotspots

for
Hepatocellular Carcinoma
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: All

Age: 18+

Code: NCT07312162

Recruiting

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

for
Untreated, Unresectable, or Metastatic Colorectal Cancer
Location: Los Angeles CA, Orange CA, Vancouver WA, San Antonio TX,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07221357

Phase 2, Phase 3, Recruiting

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

for
Glioblastoma
Location: Los Angeles CA, Scottsdale AZ, Atlanta GA, Columbus OH,
Sponsor: GT Medical Technologies, Inc.

Sex: All

Age: 18+

Code: NCT07195591

Phase 3, Recruiting

Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type

for
Agitation
Location: Chino CA, Wichita KS, St. Petersburg FL,
Sponsor: Teikoku Pharma USA, Inc.

Sex: All

Age: 0+

Code: NCT06052254

Phase 2, Recruiting

Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy

for
Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma
Location: Duarte CA, Nashville TN, Lexington KY, Atlanta GA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07003295

Phase 2, Recruiting

Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias

for
Sudden Cardiac Death, Ventricular Tachycardia,
Location: Los Angeles CA, Portland OR, Nashville TN
Sponsor: University of California, Los Angeles

Sex: All

Age: 18+

Code: NCT01013714

Phase 3, Recruiting

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

for
Non-small Cell Lung Cancer
Location: Duarte CA, Irvine CA, Phoenix AZ, Grand Junction CO,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT06686771

Phase 3, Recruiting

A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer

for
Low Grade Serous Ovarian Cancer
Location: Los Angeles CA, Phoenix AZ, Sacramento CA, Murray UT,
Sponsor: Verastem, Inc.

Sex: Female

Age: 18+

Code: NCT06072781

Phase 3, Recruiting

A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort

for
Duchenne Muscular Dystrophy
Location: Los Angeles CA, La Jolla CA, Palo Alto CA,
Sponsor: Sarepta Therapeutics, Inc.

Sex: Male

Age: 2+

Code: NCT04626674

Phase 1, Recruiting
Featured

A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan

for
Solid Tumors Harboring MET Amplification
Location: Los Angeles CA, Beverly Hills CA, Duarte CA,
Sponsor: AbbVie

Sex: All

Age: 12+

Code: NCT07196644

Phase 2, Recruiting